Skip to main content
Benjamin Chong, MD, Dermatology, Dallas, TX

Benjamin Chong MD


Assistant Professor, Dermatology, University of Texas Southwestern Medical Center, Southwestern Medical School

Join to View Full Profile
  • 5323 Harry Hines BoulevardDallas, TX 75390

  • Phone+1 214-645-2400

  • Fax+1 214-645-2405

Dr. Chong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalResidency, Dermatology, 2005 - 2008
  • Trinity Health Ann Arbor Hospital
    Trinity Health Ann Arbor HospitalInternship, Internal Medicine, 2004 - 2005
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2004

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2008 - 2026
  • MI State Medical License
    MI State Medical License 2004 - 2008
  • Dermatology
    American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
  • Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Mock Recruitment for the Study of Antimalarials in Incomplete Lupus Erythematosus Trial  
    Benjamin F Chong, Cristina Arriens, David R Karp, Judith A James, Arthritis Care & Research

Lectures

  • Complex Medical Dermatology Cases 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019
  • Dermatologists to the Rescue 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019

Press Mentions

  • Autoimmune Skin Condition Linked to Higher Risk of Heart Disease
    Autoimmune Skin Condition Linked to Higher Risk of Heart DiseaseJanuary 13th, 2025
  • Horizon Therapeutics Plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus
    Horizon Therapeutics Plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus ErythematosusJanuary 4th, 2023
  • Reviewers' List December 2017
    Reviewers' List December 2017October 3rd, 2017
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: